<html xmlns:v="urn:schemas-microsoft-com:vml" xmlns:o="urn:schemas-microsoft-com:office:office" xmlns:w="urn:schemas-microsoft-com:office:word" xmlns:m="http://schemas.microsoft.com/office/2004/12/omml" xmlns="http://www.w3.org/TR/REC-html40"><head><meta http-equiv=Content-Type content="text/html; charset=utf-8"><meta name=Generator content="Microsoft Word 12 (filtered medium)"><!--[if !mso]><style>v\:* {behavior:url(#default#VML);}
o\:* {behavior:url(#default#VML);}
w\:* {behavior:url(#default#VML);}
.shape {behavior:url(#default#VML);}
</style><![endif]--><title>Prostate Cancer News Weekly Digest</title><style><!--
/* Font Definitions */
@font-face
{font-family:Helvetica;
panose-1:2 11 6 4 2 2 2 2 2 4;}
@font-face
{font-family:Wingdings;
panose-1:5 0 0 0 0 0 0 0 0 0;}
@font-face
{font-family:"Cambria Math";
panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
{font-family:Calibri;
panose-1:2 15 5 2 2 2 4 3 2 4;}
@font-face
{font-family:Tahoma;
panose-1:2 11 6 4 3 5 4 4 2 4;}
@font-face
{font-family:Georgia;
panose-1:2 4 5 2 5 4 5 2 3 3;}
/* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
{margin:0cm;
margin-bottom:.0001pt;
font-size:12.0pt;
font-family:"Times New Roman","serif";}
h1
{mso-style-priority:9;
mso-style-link:"Heading 1 Char";
margin-top:0cm;
margin-right:0cm;
margin-bottom:7.5pt;
margin-left:0cm;
font-size:22.5pt;
font-family:"Georgia","serif";
color:#333333;
font-weight:normal;}
h2
{mso-style-priority:9;
mso-style-link:"Heading 2 Char";
margin-top:0cm;
margin-right:0cm;
margin-bottom:7.5pt;
margin-left:0cm;
font-size:15.0pt;
font-family:"Georgia","serif";
color:black;
font-weight:normal;}
h3
{mso-style-priority:9;
mso-style-link:"Heading 3 Char";
margin-top:0cm;
margin-right:0cm;
margin-bottom:7.5pt;
margin-left:0cm;
font-size:11.5pt;
font-family:"Georgia","serif";
color:#707070;
font-weight:normal;}
h4
{mso-style-priority:9;
mso-style-link:"Heading 4 Char";
margin-top:0cm;
margin-right:0cm;
margin-bottom:7.5pt;
margin-left:0cm;
font-size:13.5pt;
font-family:"Georgia","serif";
color:#303030;
font-weight:normal;}
a:link, span.MsoHyperlink
{mso-style-priority:99;
color:blue;
text-decoration:underline;}
a:visited, span.MsoHyperlinkFollowed
{mso-style-priority:99;
color:purple;
text-decoration:underline;}
p
{mso-style-priority:99;
mso-margin-top-alt:auto;
margin-right:0cm;
mso-margin-bottom-alt:auto;
margin-left:0cm;
font-size:12.0pt;
font-family:"Times New Roman","serif";}
span.Heading1Char
{mso-style-name:"Heading 1 Char";
mso-style-priority:9;
mso-style-link:"Heading 1";
font-family:"Cambria","serif";
color:#365F91;
font-weight:bold;}
span.Heading2Char
{mso-style-name:"Heading 2 Char";
mso-style-priority:9;
mso-style-link:"Heading 2";
font-family:"Cambria","serif";
color:#4F81BD;
font-weight:bold;}
span.Heading3Char
{mso-style-name:"Heading 3 Char";
mso-style-priority:9;
mso-style-link:"Heading 3";
font-family:"Cambria","serif";
color:#4F81BD;
font-weight:bold;}
span.Heading4Char
{mso-style-name:"Heading 4 Char";
mso-style-priority:9;
mso-style-link:"Heading 4";
font-family:"Cambria","serif";
color:#4F81BD;
font-weight:bold;
font-style:italic;}
p.readmsgbody, li.readmsgbody, div.readmsgbody
{mso-style-name:readmsgbody;
mso-margin-top-alt:auto;
margin-right:0cm;
mso-margin-bottom-alt:auto;
margin-left:0cm;
font-size:12.0pt;
font-family:"Times New Roman","serif";}
p.externalclass, li.externalclass, div.externalclass
{mso-style-name:externalclass;
mso-margin-top-alt:auto;
margin-right:0cm;
mso-margin-bottom-alt:auto;
margin-left:0cm;
font-size:12.0pt;
font-family:"Times New Roman","serif";}
p.h1, li.h1, div.h1
{mso-style-name:h1;
margin-top:0cm;
margin-right:0cm;
margin-bottom:7.5pt;
margin-left:0cm;
font-size:22.5pt;
font-family:"Georgia","serif";
color:#333333;}
p.h2, li.h2, div.h2
{mso-style-name:h2;
margin-top:0cm;
margin-right:0cm;
margin-bottom:7.5pt;
margin-left:0cm;
font-size:15.0pt;
font-family:"Georgia","serif";
color:black;}
p.h3, li.h3, div.h3
{mso-style-name:h3;
margin-top:0cm;
margin-right:0cm;
margin-bottom:7.5pt;
margin-left:0cm;
font-size:11.5pt;
font-family:"Georgia","serif";
color:#707070;}
p.h4, li.h4, div.h4
{mso-style-name:h4;
margin-top:0cm;
margin-right:0cm;
margin-bottom:7.5pt;
margin-left:0cm;
font-size:13.5pt;
font-family:"Georgia","serif";
color:#303030;}
p.preheadercontent, li.preheadercontent, div.preheadercontent
{mso-style-name:preheadercontent;
mso-margin-top-alt:auto;
margin-right:0cm;
mso-margin-bottom-alt:auto;
margin-left:0cm;
font-size:7.5pt;
font-family:"Helvetica","sans-serif";
color:white;}
p.headercontent, li.headercontent, div.headercontent
{mso-style-name:headercontent;
mso-margin-top-alt:auto;
margin-right:0cm;
mso-margin-bottom-alt:auto;
margin-left:0cm;
font-size:15.0pt;
font-family:"Helvetica","sans-serif";
color:#303030;
font-weight:bold;}
p.bodycontent, li.bodycontent, div.bodycontent
{mso-style-name:bodycontent;
mso-margin-top-alt:auto;
margin-right:0cm;
mso-margin-bottom-alt:auto;
margin-left:0cm;
line-height:150%;
font-size:10.0pt;
font-family:"Helvetica","sans-serif";
color:#303030;}
p.rssbutton, li.rssbutton, div.rssbutton
{mso-style-name:rssbutton;
mso-margin-top-alt:auto;
margin-right:0cm;
mso-margin-bottom-alt:auto;
margin-left:0cm;
background:#084C9E;
font-size:9.0pt;
font-family:"Helvetica","sans-serif";
color:white;
font-weight:bold;}
p.footercontent, li.footercontent, div.footercontent
{mso-style-name:footercontent;
mso-margin-top-alt:auto;
margin-right:0cm;
mso-margin-bottom-alt:auto;
margin-left:0cm;
line-height:125%;
font-size:8.5pt;
font-family:"Helvetica","sans-serif";
color:#505050;}
p.yshortcuts, li.yshortcuts, div.yshortcuts
{mso-style-name:yshortcuts;
mso-margin-top-alt:auto;
margin-right:0cm;
mso-margin-bottom-alt:auto;
margin-left:0cm;
font-size:12.0pt;
font-family:"Times New Roman","serif";}
p.yshortcuts1, li.yshortcuts1, div.yshortcuts1
{mso-style-name:yshortcuts1;
mso-margin-top-alt:auto;
margin-right:0cm;
mso-margin-bottom-alt:auto;
margin-left:0cm;
font-size:12.0pt;
font-family:"Times New Roman","serif";
color:white;
text-decoration:underline;}
p.yshortcuts2, li.yshortcuts2, div.yshortcuts2
{mso-style-name:yshortcuts2;
mso-margin-top-alt:auto;
margin-right:0cm;
mso-margin-bottom-alt:auto;
margin-left:0cm;
font-size:12.0pt;
font-family:"Times New Roman","serif";
color:black;
text-decoration:underline;}
p.yshortcuts3, li.yshortcuts3, div.yshortcuts3
{mso-style-name:yshortcuts3;
mso-margin-top-alt:auto;
margin-right:0cm;
mso-margin-bottom-alt:auto;
margin-left:0cm;
font-size:12.0pt;
font-family:"Times New Roman","serif";
color:#084C9E;
text-decoration:underline;}
p.yshortcuts4, li.yshortcuts4, div.yshortcuts4
{mso-style-name:yshortcuts4;
mso-margin-top-alt:auto;
margin-right:0cm;
mso-margin-bottom-alt:auto;
margin-left:0cm;
font-size:12.0pt;
font-family:"Times New Roman","serif";
color:#505050;
text-decoration:underline;}
span.bodycontent1
{mso-style-name:bodycontent1;
font-family:"Helvetica","sans-serif";
color:#303030;}
span.org
{mso-style-name:org;}
span.locality
{mso-style-name:locality;}
span.region
{mso-style-name:region;}
span.postal-code
{mso-style-name:postal-code;}
span.EmailStyle45
{mso-style-type:personal-reply;
font-family:"Calibri","sans-serif";
color:#1F497D;}
.MsoChpDefault
{mso-style-type:export-only;
font-size:10.0pt;}
@page WordSection1
{size:612.0pt 792.0pt;
margin:72.0pt 72.0pt 72.0pt 72.0pt;}
div.WordSection1
{page:WordSection1;}
/* List Definitions */
@list l0
{mso-list-id:1690061411;
mso-list-template-ids:-57391960;}
@list l0:level1
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:36.0pt;
mso-level-number-position:left;
text-indent:-18.0pt;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
ol
{margin-bottom:0cm;}
ul
{margin-bottom:0cm;}
--></style><!--[if gte mso 9]><xml>
<o:shapedefaults v:ext="edit" spidmax="1026" />
</xml><![endif]--><!--[if gte mso 9]><xml>
<o:shapelayout v:ext="edit">
<o:idmap v:ext="edit" data="1" />
</o:shapelayout></xml><![endif]--></head><body bgcolor="#EBEBEB" lang=EN-CA link=blue vlink=purple><div class=WordSection1><p class=MsoNormal><span style='font-size:11.0pt;font-family:"Calibri","sans-serif";color:#1F497D'>Hi all:<o:p></o:p></span></p><p class=MsoNormal><span style='font-size:11.0pt;font-family:"Calibri","sans-serif";color:#1F497D'>Below is an e-letter with a number of interesting topics.<o:p></o:p></span></p><p class=MsoNormal><span style='font-size:11.0pt;font-family:"Calibri","sans-serif";color:#1F497D'>Thx.<o:p></o:p></span></p><p class=MsoNormal><span style='font-size:11.0pt;font-family:"Calibri","sans-serif";color:#1F497D'>Glen<o:p></o:p></span></p><p class=MsoNormal><span style='font-size:11.0pt;font-family:"Calibri","sans-serif";color:#1F497D'><o:p> </o:p></span></p><div><div style='border:none;border-top:solid #B5C4DF 1.0pt;padding:3.0pt 0cm 0cm 0cm'><p class=MsoNormal><b><span lang=EN-US style='font-size:10.0pt;font-family:"Tahoma","sans-serif"'>From:</span></b><span lang=EN-US style='font-size:10.0pt;font-family:"Tahoma","sans-serif"'> Prostate Cancer News Today <br><b>Subject:</b> Prostate Cancer News Weekly Digest<o:p></o:p></span></p></div></div><p class=MsoNormal><o:p> </o:p></p><div align=center><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;background:#EBEBEB'><tr><td valign=top style='padding:0cm 0cm 0cm 0cm'><div align=center><table class=MsoNormalTable border=1 cellspacing=0 cellpadding=0 width=600 style='width:450.0pt;background:#666666;border:none;border-bottom:solid #666666 1.5pt'><tr><td valign=top style='border:none;padding:7.5pt 7.5pt 7.5pt 7.5pt'><div align=center><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%'><tr><td valign=top style='padding:0cm 15.0pt 0cm 0cm'><p class=MsoNormal><span style='font-size:7.5pt;font-family:"Helvetica","sans-serif";color:white'>See below for a daily digest of the latest Prostate Cancer news!<o:p></o:p></span></p></td><td width=200 valign=top style='width:150.0pt;padding:0cm 0cm 0cm 0cm'><p class=MsoNormal><span style='font-size:7.5pt;font-family:"Helvetica","sans-serif";color:white'>Is this email not displaying correctly?<br><a href="http://us5.campaign-archive2.com/?u=52c64784d386bd00ea57ee792&id=458aa9aafa&e=d367b0fd99" target="_blank"><span style='color:white'>View it in your browser</span></a>. <o:p></o:p></span></p></td></tr></table></div></td></tr></table></div><p class=MsoNormal align=center style='text-align:center'><o:p> </o:p></p><div align=center><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width=600 style='width:450.0pt' id=templateContainer><tr><td valign=top style='border:none;border-bottom:solid #D9D9D9 1.0pt;background:white;padding:0cm 0cm 0cm 0cm' id=templateHeader><div align=center><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%'><tr><td style='padding:15.0pt 15.0pt 15.0pt 15.0pt'><p class=MsoNormal><b><span style='font-size:15.0pt;font-family:"Helvetica","sans-serif";color:#303030'><img border=0 id="_x0000_i1025" src="http://gallery.mailchimp.com/653153ae841fd11de66ad181a/images/transparent.gif"><o:p></o:p></span></b></p></td></tr></table></div></td></tr><tr><td valign=top style='padding:0cm 0cm 0cm 0cm'><div align=center><table class=MsoNormalTable border=1 cellspacing=0 cellpadding=0 width=600 style='width:450.0pt;background:white;border:none;border-bottom:solid #CACACA 1.0pt' id=templateBody><tr><td valign=top style='border:none;padding:30.0pt 15.0pt 30.0pt 15.0pt'><div align=center><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%'><tr><td valign=top style='padding:0cm 0cm 15.0pt 0cm'><div><p class=MsoNormal align=center style='text-align:center;line-height:150%'><span style='font-size:10.0pt;line-height:150%;font-family:"Helvetica","sans-serif";color:#303030'><a href="http://prostatecancernewstoday.us5.list-manage1.com/track/click?u=52c64784d386bd00ea57ee792&id=26ad169df6&e=d367b0fd99" target="_blank"><span style='color:#084C9E;text-decoration:none'><img border=0 width=66 height=66 id="_x0000_i1026" src="http://ab166704.adbutler-zilon.com/adserve/;ID=166704;size=300x250;setID=203705;type=img;uid=458aa9aafad367b0fd99;"></span></a><o:p></o:p></span></p><h1>Prostate Cancer News Weekly Digest<o:p></o:p></h1><p class=MsoNormal style='line-height:150%'><span style='font-size:10.0pt;line-height:150%;font-family:"Helvetica","sans-serif";color:#303030'><br><strong><span style='font-family:"Helvetica","sans-serif"'>Featured Article</span></strong>: <u><a href="http://prostatecancernewstoday.us5.list-manage1.com/track/click?u=52c64784d386bd00ea57ee792&id=93cbb4acff&e=d367b0fd99" target="_blank"><span style='color:#084C9E'>F</span></a></u><a href="http://prostatecancernewstoday.us5.list-manage2.com/track/click?u=52c64784d386bd00ea57ee792&id=8d408b8315&e=d367b0fd99"><span style='color:#084C9E'>inding Out About Prostate Cancer Clinical Trials</span></a><br><strong><span style='font-family:"Helvetica","sans-serif"'>Contents:</span></strong><br><br><o:p></o:p></span></p><ul type=disc><li class=MsoNormal style='color:#303030;mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;line-height:150%;mso-list:l0 level1 lfo1'><span style='font-size:10.0pt;line-height:150%;font-family:"Helvetica","sans-serif"'><a href="#mctoc1"><span style='color:#084C9E'>7 Benefits of Good Nutrition During Cancer Treatment</span></a><o:p></o:p></span></li><li class=MsoNormal style='color:#303030;mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;line-height:150%;mso-list:l0 level1 lfo1'><span style='font-size:10.0pt;line-height:150%;font-family:"Helvetica","sans-serif"'><a href="#mctoc2"><span style='color:#084C9E'>Novel Method Identifies Prostate Cancer Patients Who Require Aggressive Treatments</span></a><o:p></o:p></span></li><li class=MsoNormal style='color:#303030;mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;line-height:150%;mso-list:l0 level1 lfo1'><span style='font-size:10.0pt;line-height:150%;font-family:"Helvetica","sans-serif"'><a href="#mctoc3"><span style='color:#084C9E'>Loss of Commonly Mutated Gene in Prostate Tumors May Be Potential Biomarker for Targeted Treatment</span></a><o:p></o:p></span></li><li class=MsoNormal style='color:#303030;mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;line-height:150%;mso-list:l0 level1 lfo1'><span style='font-size:10.0pt;line-height:150%;font-family:"Helvetica","sans-serif"'><a href="#mctoc4"><span style='color:#084C9E'>PET/CT Scans for Prostate Cancer Patients at Risk of Recurrence Offered at Loyola</span></a><o:p></o:p></span></li><li class=MsoNormal style='color:#303030;mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;line-height:150%;mso-list:l0 level1 lfo1'><span style='font-size:10.0pt;line-height:150%;font-family:"Helvetica","sans-serif"'><a href="#mctoc5"><span style='color:#084C9E'>Mathematical Model May Predict Relapse Times in Prostate Cancer Surgery Patients</span></a><o:p></o:p></span></li><li class=MsoNormal style='color:#303030;mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;line-height:150%;mso-list:l0 level1 lfo1'><span style='font-size:10.0pt;line-height:150%;font-family:"Helvetica","sans-serif"'><a href="#mctoc6"><span style='color:#084C9E'>Metastatic Prostate Cancer Patients in UK Can Now Have Routine Radium-223 Therapy</span></a><o:p></o:p></span></li></ul><p class=MsoNormal style='line-height:150%'><strong><span style='font-size:10.0pt;line-height:150%;font-family:"Helvetica","sans-serif";color:#303030;background:#BD081C'>SaveSaveSaveSave</span></strong><span style='font-size:10.0pt;line-height:150%;font-family:"Helvetica","sans-serif";color:#303030'><o:p></o:p></span></p></div></td></tr><tr><td valign=top style='padding:0cm 0cm 0cm 0cm'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%'><tr><td style='padding:7.5pt 0cm 0cm 0cm'><h2><a name=mctoc1>7 Benefits of Good Nutrition During Cancer Treatment<o:p></o:p></a></h2><h3>Sep 12, 2016 08:46 am | Andreia Peixoto<o:p></o:p></h3><h1> <o:p></o:p></h1><p style='line-height:150%'><span style='font-size:10.0pt;line-height:150%;font-family:"Helvetica","sans-serif";color:#303030'><img border=0 width=740 id="_x0000_i1027" src="https://prostatecancernewstoday.com/wp-content/uploads/2016/09/news_18_Artboard-343-copy-217.png" alt="news_18_Artboard 343 copy 217">According to the American Cancer Society, a healthy diet is always good for you, but it’s especially important to pay attention to nutrition if you have cancer. The way your body uses nutrients and tolerates some foods can be much different during cancer treatments, however, so do ask your treatment team for advice on the best diet for you. Then, try to […]<o:p></o:p></span></p><p style='line-height:150%'><span style='font-size:10.0pt;line-height:150%;font-family:"Helvetica","sans-serif";color:#303030'>The post </span><a href="http://prostatecancernewstoday.us5.list-manage.com/track/click?u=52c64784d386bd00ea57ee792&id=5df9982336&e=d367b0fd99"><span style='font-size:10.0pt;line-height:150%;font-family:"Helvetica","sans-serif";color:#084C9E'>7 Benefits of Good Nutrition During Cancer Treatment</span></a><span style='font-size:10.0pt;line-height:150%;font-family:"Helvetica","sans-serif";color:#303030'> appeared first on </span><a href="http://prostatecancernewstoday.us5.list-manage.com/track/click?u=52c64784d386bd00ea57ee792&id=e14a02fbc9&e=d367b0fd99"><span style='font-size:10.0pt;line-height:150%;font-family:"Helvetica","sans-serif";color:#084C9E'>Prostate Cancer News Today</span></a><span style='font-size:10.0pt;line-height:150%;font-family:"Helvetica","sans-serif";color:#303030'>.<o:p></o:p></span></p></td></tr><tr><td valign=top style='padding:7.5pt 0cm 7.5pt 0cm'><table class=MsoNormalTable border=1 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border:none;border-bottom:solid #D9D9D9 1.0pt;-moz-border-radius: 5px;-webkitborder-radius: 5px;border-radius: 5px'><tr><td valign=top style='border:none;padding:0cm 0cm 15.0pt 0cm'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 style='background:#084C9E'><tr><td style='padding:7.5pt 7.5pt 7.5pt 7.5pt'><p class=MsoNormal align=center style='text-align:center'><a href="http://prostatecancernewstoday.us5.list-manage.com/track/click?u=52c64784d386bd00ea57ee792&id=9528fa059f&e=d367b0fd99" target="_blank"><b><span style='font-size:9.0pt;font-family:"Helvetica","sans-serif";color:white;text-decoration:none'>Read More</span></b></a><b><span style='font-size:9.0pt;font-family:"Helvetica","sans-serif";color:white'> <o:p></o:p></span></b></p></td></tr></table></td><td width=60 style='width:45.0pt;border:none;padding:0cm 0cm 15.0pt 0cm'><p class=MsoNormal style='line-height:150%'><a href="http://prostatecancernewstoday.us5.list-manage.com/track/click?u=52c64784d386bd00ea57ee792&id=1dfb0c6089&e=d367b0fd99" target="_blank"><span style='font-size:10.0pt;line-height:150%;font-family:"Helvetica","sans-serif";color:#084C9E;text-decoration:none'><img border=0 width=55 height=20 id="_x0000_i1028" src="http://cdn-images.mailchimp.com/social_connect_tweet.png" alt="share on Twitter"></span></a><span style='font-size:10.0pt;line-height:150%;font-family:"Helvetica","sans-serif";color:#303030'><o:p></o:p></span></p></td><td width=60 style='width:45.0pt;border:none;padding:0cm 0cm 15.0pt 0cm'><p class=MsoNormal style='line-height:150%'><a href="http://prostatecancernewstoday.us5.list-manage.com/track/click?u=52c64784d386bd00ea57ee792&id=92464d9a6c&e=d367b0fd99" title="Like 7 Benefits of Good Nutrition During Cancer Treatment on Facebook" id=fblike-9bf64d0f><span style='font-size:10.0pt;line-height:150%;font-family:"Helvetica","sans-serif";color:#084C9E;text-decoration:none'><img border=0 width=48 height=20 id="_x0000_i1029" src="http://cdn-images.mailchimp.com/fb/like.gif" alt="Like 7 Benefits of Good Nutrition During Cancer Treatment on Facebook"></span></a><span style='font-size:10.0pt;line-height:150%;font-family:"Helvetica","sans-serif";color:#303030'><o:p></o:p></span></p></td></tr></table></td></tr></table><p class=MsoNormal><span style='display:none'><o:p> </o:p></span></p><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%'><tr><td style='padding:7.5pt 0cm 0cm 0cm'><h2><a name=mctoc2></a>Novel Method Identifies Prostate Cancer Patients Who Require Aggressive Treatments<o:p></o:p></h2><h3>Sep 12, 2016 08:02 am | Ines Martins, PhD<o:p></o:p></h3><h1> <o:p></o:p></h1><p style='line-height:150%'><span style='font-size:10.0pt;line-height:150%;font-family:"Helvetica","sans-serif";color:#303030'><img border=0 width=740 id="_x0000_i1030" src="https://prostatecancernewstoday.com/wp-content/uploads/2016/09/shutterstock_369907334.jpg" alt="Prostate cancer subtypes">Researchers at Cedar-Sinai have developed a novel way to identify which prostate cancer patients will develop aggressive types of the disease based on the genes that are activated in each individual tumor. The study, “Integrated Classification of Prostate Cancer Reveals a Novel Luminal Subtype with Poor Outcome,” published in Cancer Research, divides prostate cancer patients […]<o:p></o:p></span></p><p style='line-height:150%'><span style='font-size:10.0pt;line-height:150%;font-family:"Helvetica","sans-serif";color:#303030'>The post </span><a href="http://prostatecancernewstoday.us5.list-manage.com/track/click?u=52c64784d386bd00ea57ee792&id=50787b01f4&e=d367b0fd99"><span style='font-size:10.0pt;line-height:150%;font-family:"Helvetica","sans-serif";color:#084C9E'>Novel Method Identifies Prostate Cancer Patients Who Require Aggressive Treatments</span></a><span style='font-size:10.0pt;line-height:150%;font-family:"Helvetica","sans-serif";color:#303030'> appeared first on </span><a href="http://prostatecancernewstoday.us5.list-manage1.com/track/click?u=52c64784d386bd00ea57ee792&id=23c2d18084&e=d367b0fd99"><span style='font-size:10.0pt;line-height:150%;font-family:"Helvetica","sans-serif";color:#084C9E'>Prostate Cancer News Today</span></a><span style='font-size:10.0pt;line-height:150%;font-family:"Helvetica","sans-serif";color:#303030'>.<o:p></o:p></span></p></td></tr><tr><td valign=top style='padding:7.5pt 0cm 7.5pt 0cm'><table class=MsoNormalTable border=1 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border:none;border-bottom:solid #D9D9D9 1.0pt;-moz-border-radius: 5px;-webkitborder-radius: 5px;border-radius: 5px'><tr><td valign=top style='border:none;padding:0cm 0cm 15.0pt 0cm'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 style='background:#084C9E'><tr><td style='padding:7.5pt 7.5pt 7.5pt 7.5pt'><p class=MsoNormal align=center style='text-align:center'><a href="http://prostatecancernewstoday.us5.list-manage1.com/track/click?u=52c64784d386bd00ea57ee792&id=404d3c344e&e=d367b0fd99" target="_blank"><b><span style='font-size:9.0pt;font-family:"Helvetica","sans-serif";color:white;text-decoration:none'>Read More</span></b></a><b><span style='font-size:9.0pt;font-family:"Helvetica","sans-serif";color:white'> <o:p></o:p></span></b></p></td></tr></table></td><td width=60 style='width:45.0pt;border:none;padding:0cm 0cm 15.0pt 0cm'><p class=MsoNormal style='line-height:150%'><a href="http://prostatecancernewstoday.us5.list-manage1.com/track/click?u=52c64784d386bd00ea57ee792&id=28b8dc536b&e=d367b0fd99" target="_blank"><span style='font-size:10.0pt;line-height:150%;font-family:"Helvetica","sans-serif";color:#084C9E;text-decoration:none'><img border=0 width=55 height=20 id="_x0000_i1031" src="http://cdn-images.mailchimp.com/social_connect_tweet.png" alt="share on Twitter"></span></a><span style='font-size:10.0pt;line-height:150%;font-family:"Helvetica","sans-serif";color:#303030'><o:p></o:p></span></p></td><td width=60 style='width:45.0pt;border:none;padding:0cm 0cm 15.0pt 0cm'><p class=MsoNormal style='line-height:150%'><a href="http://prostatecancernewstoday.us5.list-manage1.com/track/click?u=52c64784d386bd00ea57ee792&id=e37794bc59&e=d367b0fd99" title="Like Novel Method Identifies Prostate Cancer Patients Who Require Aggressive Treatments on Facebook" id=fblike-d8d03def><span style='font-size:10.0pt;line-height:150%;font-family:"Helvetica","sans-serif";color:#084C9E;text-decoration:none'><img border=0 width=48 height=20 id="_x0000_i1032" src="http://cdn-images.mailchimp.com/fb/like.gif" alt="Like Novel Method Identifies Prostate Cancer Patients Who Require Aggressive Treatments on Facebook"></span></a><span style='font-size:10.0pt;line-height:150%;font-family:"Helvetica","sans-serif";color:#303030'><o:p></o:p></span></p></td></tr></table></td></tr></table><p class=MsoNormal><span style='display:none'><o:p> </o:p></span></p><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%'><tr><td style='padding:7.5pt 0cm 0cm 0cm'><h2><a name=mctoc3></a>Loss of Commonly Mutated Gene in Prostate Tumors May Be Potential Biomarker for Targeted Treatment<o:p></o:p></h2><h3>Sep 09, 2016 11:10 am | Carolina Henriques<o:p></o:p></h3><h1> <o:p></o:p></h1><p style='line-height:150%'><span style='font-size:10.0pt;line-height:150%;font-family:"Helvetica","sans-serif";color:#303030'><img border=0 width=740 id="_x0000_i1033" src="https://prostatecancernewstoday.com/wp-content/uploads/2016/09/shutterstock_118948423.jpg" alt="gene mutation as potential biomarker">A new research study found that the loss of CHD1, one of the most commonly mutated genes in prostate tumors, may be a potential biomarker for targeted prostate cancer therapy. In the study, “Loss of CHD1 causes DNA repair defects and enhances prostate cancer therapeutic responsiveness,” published in EMBO Reports, researchers showed that CDH1 is involved in DNA […]<o:p></o:p></span></p><p style='line-height:150%'><span style='font-size:10.0pt;line-height:150%;font-family:"Helvetica","sans-serif";color:#303030'>The post </span><a href="http://prostatecancernewstoday.us5.list-manage.com/track/click?u=52c64784d386bd00ea57ee792&id=53e265428b&e=d367b0fd99"><span style='font-size:10.0pt;line-height:150%;font-family:"Helvetica","sans-serif";color:#084C9E'>Loss of Commonly Mutated Gene in Prostate Tumors May Be Potential Biomarker for Targeted Treatment</span></a><span style='font-size:10.0pt;line-height:150%;font-family:"Helvetica","sans-serif";color:#303030'> appeared first on </span><a href="http://prostatecancernewstoday.us5.list-manage.com/track/click?u=52c64784d386bd00ea57ee792&id=62e1e22942&e=d367b0fd99"><span style='font-size:10.0pt;line-height:150%;font-family:"Helvetica","sans-serif";color:#084C9E'>Prostate Cancer News Today</span></a><span style='font-size:10.0pt;line-height:150%;font-family:"Helvetica","sans-serif";color:#303030'>.<o:p></o:p></span></p></td></tr><tr><td valign=top style='padding:7.5pt 0cm 7.5pt 0cm'><table class=MsoNormalTable border=1 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border:none;border-bottom:solid #D9D9D9 1.0pt;-moz-border-radius: 5px;-webkitborder-radius: 5px;border-radius: 5px'><tr><td valign=top style='border:none;padding:0cm 0cm 15.0pt 0cm'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 style='background:#084C9E'><tr><td style='padding:7.5pt 7.5pt 7.5pt 7.5pt'><p class=MsoNormal align=center style='text-align:center'><a href="http://prostatecancernewstoday.us5.list-manage2.com/track/click?u=52c64784d386bd00ea57ee792&id=6e746270d3&e=d367b0fd99" target="_blank"><b><span style='font-size:9.0pt;font-family:"Helvetica","sans-serif";color:white;text-decoration:none'>Read More</span></b></a><b><span style='font-size:9.0pt;font-family:"Helvetica","sans-serif";color:white'> <o:p></o:p></span></b></p></td></tr></table></td><td width=60 style='width:45.0pt;border:none;padding:0cm 0cm 15.0pt 0cm'><p class=MsoNormal style='line-height:150%'><a href="http://prostatecancernewstoday.us5.list-manage.com/track/click?u=52c64784d386bd00ea57ee792&id=14339749db&e=d367b0fd99" target="_blank"><span style='font-size:10.0pt;line-height:150%;font-family:"Helvetica","sans-serif";color:#084C9E;text-decoration:none'><img border=0 width=55 height=20 id="_x0000_i1034" src="http://cdn-images.mailchimp.com/social_connect_tweet.png" alt="share on Twitter"></span></a><span style='font-size:10.0pt;line-height:150%;font-family:"Helvetica","sans-serif";color:#303030'><o:p></o:p></span></p></td><td width=60 style='width:45.0pt;border:none;padding:0cm 0cm 15.0pt 0cm'><p class=MsoNormal style='line-height:150%'><a href="http://prostatecancernewstoday.us5.list-manage.com/track/click?u=52c64784d386bd00ea57ee792&id=4f3ff80414&e=d367b0fd99" title="Like Loss of Commonly Mutated Gene in Prostate Tumors May Be Potential Biomarker for Targeted Treatment on Facebook" id=fblike-f53b9f92><span style='font-size:10.0pt;line-height:150%;font-family:"Helvetica","sans-serif";color:#084C9E;text-decoration:none'><img border=0 width=48 height=20 id="_x0000_i1035" src="http://cdn-images.mailchimp.com/fb/like.gif" alt="Like Loss of Commonly Mutated Gene in Prostate Tumors May Be Potential Biomarker for Targeted Treatment on Facebook"></span></a><span style='font-size:10.0pt;line-height:150%;font-family:"Helvetica","sans-serif";color:#303030'><o:p></o:p></span></p></td></tr></table></td></tr></table><p class=MsoNormal><span style='display:none'><o:p> </o:p></span></p><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%'><tr><td style='padding:7.5pt 0cm 0cm 0cm'><h2><a name=mctoc4></a>PET/CT Scans for Prostate Cancer Patients at Risk of Recurrence Offered at Loyola<o:p></o:p></h2><h3>Sep 08, 2016 12:04 pm | Ines Martins, PhD<o:p></o:p></h3><h1> <o:p></o:p></h1><p style='line-height:150%'><span style='font-size:10.0pt;line-height:150%;font-family:"Helvetica","sans-serif";color:#303030'><img border=0 width=740 id="_x0000_i1036" src="https://prostatecancernewstoday.com/wp-content/uploads/2016/09/shutterstock_74308516.jpg" alt="prostate cancer scan">Detecting the exact location and extent of prostate cancer that has returned and metastasized in patients after initial treatment is now more likely, following the recent approval of a new positron emission tomography (PET) scan tracer that accurately targets prostate cancer cells. Loyola Medicine announced it is using the new tracer, and is the first center in the […]<o:p></o:p></span></p><p style='line-height:150%'><span style='font-size:10.0pt;line-height:150%;font-family:"Helvetica","sans-serif";color:#303030'>The post </span><a href="http://prostatecancernewstoday.us5.list-manage.com/track/click?u=52c64784d386bd00ea57ee792&id=2ea0afd7f2&e=d367b0fd99"><span style='font-size:10.0pt;line-height:150%;font-family:"Helvetica","sans-serif";color:#084C9E'>PET/CT Scans for Prostate Cancer Patients at Risk of Recurrence Offered at Loyola</span></a><span style='font-size:10.0pt;line-height:150%;font-family:"Helvetica","sans-serif";color:#303030'> appeared first on </span><a href="http://prostatecancernewstoday.us5.list-manage.com/track/click?u=52c64784d386bd00ea57ee792&id=3852620f5f&e=d367b0fd99"><span style='font-size:10.0pt;line-height:150%;font-family:"Helvetica","sans-serif";color:#084C9E'>Prostate Cancer News Today</span></a><span style='font-size:10.0pt;line-height:150%;font-family:"Helvetica","sans-serif";color:#303030'>.<o:p></o:p></span></p></td></tr><tr><td valign=top style='padding:7.5pt 0cm 7.5pt 0cm'><table class=MsoNormalTable border=1 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border:none;border-bottom:solid #D9D9D9 1.0pt;-moz-border-radius: 5px;-webkitborder-radius: 5px;border-radius: 5px'><tr><td valign=top style='border:none;padding:0cm 0cm 15.0pt 0cm'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 style='background:#084C9E'><tr><td style='padding:7.5pt 7.5pt 7.5pt 7.5pt'><p class=MsoNormal align=center style='text-align:center'><a href="http://prostatecancernewstoday.us5.list-manage.com/track/click?u=52c64784d386bd00ea57ee792&id=1c0bfa49f2&e=d367b0fd99" target="_blank"><b><span style='font-size:9.0pt;font-family:"Helvetica","sans-serif";color:white;text-decoration:none'>Read More</span></b></a><b><span style='font-size:9.0pt;font-family:"Helvetica","sans-serif";color:white'> <o:p></o:p></span></b></p></td></tr></table></td><td width=60 style='width:45.0pt;border:none;padding:0cm 0cm 15.0pt 0cm'><p class=MsoNormal style='line-height:150%'><a href="http://prostatecancernewstoday.us5.list-manage2.com/track/click?u=52c64784d386bd00ea57ee792&id=f22fd0b352&e=d367b0fd99" target="_blank"><span style='font-size:10.0pt;line-height:150%;font-family:"Helvetica","sans-serif";color:#084C9E;text-decoration:none'><img border=0 width=55 height=20 id="_x0000_i1037" src="http://cdn-images.mailchimp.com/social_connect_tweet.png" alt="share on Twitter"></span></a><span style='font-size:10.0pt;line-height:150%;font-family:"Helvetica","sans-serif";color:#303030'><o:p></o:p></span></p></td><td width=60 style='width:45.0pt;border:none;padding:0cm 0cm 15.0pt 0cm'><p class=MsoNormal style='line-height:150%'><a href="http://prostatecancernewstoday.us5.list-manage.com/track/click?u=52c64784d386bd00ea57ee792&id=101ee09ec7&e=d367b0fd99" title="Like PET/CT Scans for Prostate Cancer Patients at Risk of Recurrence Offered at Loyola on Facebook" id=fblike-96422b2c><span style='font-size:10.0pt;line-height:150%;font-family:"Helvetica","sans-serif";color:#084C9E;text-decoration:none'><img border=0 width=48 height=20 id="_x0000_i1038" src="http://cdn-images.mailchimp.com/fb/like.gif" alt="Like PET/CT Scans for Prostate Cancer Patients at Risk of Recurrence Offered at Loyola on Facebook"></span></a><span style='font-size:10.0pt;line-height:150%;font-family:"Helvetica","sans-serif";color:#303030'><o:p></o:p></span></p></td></tr></table></td></tr></table><p class=MsoNormal><span style='display:none'><o:p> </o:p></span></p><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%'><tr><td style='padding:7.5pt 0cm 0cm 0cm'><h2><a name=mctoc5></a>Mathematical Model May Predict Relapse Times in Prostate Cancer Surgery Patients<o:p></o:p></h2><h3>Sep 07, 2016 10:30 am | Ines Martins, PhD<o:p></o:p></h3><h1> <o:p></o:p></h1><p style='line-height:150%'><span style='font-size:10.0pt;line-height:150%;font-family:"Helvetica","sans-serif";color:#303030'><img border=0 width=740 id="_x0000_i1039" src="https://prostatecancernewstoday.com/wp-content/uploads/2016/09/shutterstock_129116279.jpg" alt="mathematical model">A mathematical model based on four consecutive measures of prostate-specific antigen (PSA) levels can be used to predict the time to relapse in patients who underwent prostate cancer surgery, according to a study published in Cancer Research. The method detailed in the study, “A Simple PSA-Based Computational Approach Predicts the Timing of Cancer Relapse in Prostatectomized […]<o:p></o:p></span></p><p style='line-height:150%'><span style='font-size:10.0pt;line-height:150%;font-family:"Helvetica","sans-serif";color:#303030'>The post </span><a href="http://prostatecancernewstoday.us5.list-manage.com/track/click?u=52c64784d386bd00ea57ee792&id=e00720480f&e=d367b0fd99"><span style='font-size:10.0pt;line-height:150%;font-family:"Helvetica","sans-serif";color:#084C9E'>Mathematical Model May Predict Relapse Times in Prostate Cancer Surgery Patients</span></a><span style='font-size:10.0pt;line-height:150%;font-family:"Helvetica","sans-serif";color:#303030'> appeared first on </span><a href="http://prostatecancernewstoday.us5.list-manage.com/track/click?u=52c64784d386bd00ea57ee792&id=e296e2c19f&e=d367b0fd99"><span style='font-size:10.0pt;line-height:150%;font-family:"Helvetica","sans-serif";color:#084C9E'>Prostate Cancer News Today</span></a><span style='font-size:10.0pt;line-height:150%;font-family:"Helvetica","sans-serif";color:#303030'>.<o:p></o:p></span></p></td></tr><tr><td valign=top style='padding:7.5pt 0cm 7.5pt 0cm'><table class=MsoNormalTable border=1 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border:none;border-bottom:solid #D9D9D9 1.0pt;-moz-border-radius: 5px;-webkitborder-radius: 5px;border-radius: 5px'><tr><td valign=top style='border:none;padding:0cm 0cm 15.0pt 0cm'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 style='background:#084C9E'><tr><td style='padding:7.5pt 7.5pt 7.5pt 7.5pt'><p class=MsoNormal align=center style='text-align:center'><a href="http://prostatecancernewstoday.us5.list-manage.com/track/click?u=52c64784d386bd00ea57ee792&id=4d9dc19e7b&e=d367b0fd99" target="_blank"><b><span style='font-size:9.0pt;font-family:"Helvetica","sans-serif";color:white;text-decoration:none'>Read More</span></b></a><b><span style='font-size:9.0pt;font-family:"Helvetica","sans-serif";color:white'> <o:p></o:p></span></b></p></td></tr></table></td><td width=60 style='width:45.0pt;border:none;padding:0cm 0cm 15.0pt 0cm'><p class=MsoNormal style='line-height:150%'><a href="http://prostatecancernewstoday.us5.list-manage1.com/track/click?u=52c64784d386bd00ea57ee792&id=b440bb7121&e=d367b0fd99" target="_blank"><span style='font-size:10.0pt;line-height:150%;font-family:"Helvetica","sans-serif";color:#084C9E;text-decoration:none'><img border=0 width=55 height=20 id="_x0000_i1040" src="http://cdn-images.mailchimp.com/social_connect_tweet.png" alt="share on Twitter"></span></a><span style='font-size:10.0pt;line-height:150%;font-family:"Helvetica","sans-serif";color:#303030'><o:p></o:p></span></p></td><td width=60 style='width:45.0pt;border:none;padding:0cm 0cm 15.0pt 0cm'><p class=MsoNormal style='line-height:150%'><a href="http://prostatecancernewstoday.us5.list-manage.com/track/click?u=52c64784d386bd00ea57ee792&id=63812978bd&e=d367b0fd99" title="Like Mathematical Model May Predict Relapse Times in Prostate Cancer Surgery Patients on Facebook" id=fblike-ee14821e><span style='font-size:10.0pt;line-height:150%;font-family:"Helvetica","sans-serif";color:#084C9E;text-decoration:none'><img border=0 width=48 height=20 id="_x0000_i1041" src="http://cdn-images.mailchimp.com/fb/like.gif" alt="Like Mathematical Model May Predict Relapse Times in Prostate Cancer Surgery Patients on Facebook"></span></a><span style='font-size:10.0pt;line-height:150%;font-family:"Helvetica","sans-serif";color:#303030'><o:p></o:p></span></p></td></tr></table></td></tr></table><p class=MsoNormal><span style='display:none'><o:p> </o:p></span></p><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%'><tr><td style='padding:7.5pt 0cm 0cm 0cm'><h2><a name=mctoc6></a>Metastatic Prostate Cancer Patients in UK Can Now Have Routine Radium-223 Therapy<o:p></o:p></h2><h3>Sep 06, 2016 03:31 pm | Charles Moore<o:p></o:p></h3><h1> <o:p></o:p></h1><p style='line-height:150%'><span style='font-size:10.0pt;line-height:150%;font-family:"Helvetica","sans-serif";color:#303030'><img border=0 width=740 id="_x0000_i1042" src="https://prostatecancernewstoday.com/wp-content/uploads/2016/06/shutterstock_277806740-1024x683.jpg" alt="prostate cancer and radium-223">The U.K.’s National Institute for Clinical Excellence (NICE) has approved radium-223 to treat prostate cancer that has spread to the bones for routine National Health Service (NHS) use. The approval comes in the wake of new information about how the effectiveness of radium-223 internal radiation therapy compares with treatments currently available for this type of prostate cancer, according to […]<o:p></o:p></span></p><p style='line-height:150%'><span style='font-size:10.0pt;line-height:150%;font-family:"Helvetica","sans-serif";color:#303030'>The post </span><a href="http://prostatecancernewstoday.us5.list-manage1.com/track/click?u=52c64784d386bd00ea57ee792&id=50ecf20d91&e=d367b0fd99"><span style='font-size:10.0pt;line-height:150%;font-family:"Helvetica","sans-serif";color:#084C9E'>Metastatic Prostate Cancer Patients in UK Can Now Have Routine Radium-223 Therapy</span></a><span style='font-size:10.0pt;line-height:150%;font-family:"Helvetica","sans-serif";color:#303030'> appeared first on </span><a href="http://prostatecancernewstoday.us5.list-manage.com/track/click?u=52c64784d386bd00ea57ee792&id=1915c4408a&e=d367b0fd99"><span style='font-size:10.0pt;line-height:150%;font-family:"Helvetica","sans-serif";color:#084C9E'>Prostate Cancer News Today</span></a><span style='font-size:10.0pt;line-height:150%;font-family:"Helvetica","sans-serif";color:#303030'>.<o:p></o:p></span></p></td></tr><tr><td valign=top style='padding:7.5pt 0cm 7.5pt 0cm'><table class=MsoNormalTable border=1 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border:none;border-bottom:solid #D9D9D9 1.0pt;-moz-border-radius: 5px;-webkitborder-radius: 5px;border-radius: 5px'><tr><td valign=top style='border:none;padding:0cm 0cm 15.0pt 0cm'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 style='background:#084C9E'><tr><td style='padding:7.5pt 7.5pt 7.5pt 7.5pt'><p class=MsoNormal align=center style='text-align:center'><b><span style='font-size:9.0pt;font-family:"Helvetica","sans-serif";color:white'><a href="http://prostatecancernewstoday.us5.list-manage.com/track/click?u=52c64784d386bd00ea57ee792&id=3ad4aa18ec&e=d367b0fd99" target="_blank"><span style='color:white;text-decoration:none'>Read More</span></a> <o:p></o:p></span></b></p></td></tr></table></td><td width=60 style='width:45.0pt;border:none;padding:0cm 0cm 15.0pt 0cm'><p class=MsoNormal style='line-height:150%'><span style='font-size:10.0pt;line-height:150%;font-family:"Helvetica","sans-serif";color:#303030'><a href="http://prostatecancernewstoday.us5.list-manage1.com/track/click?u=52c64784d386bd00ea57ee792&id=ab5b17f1c2&e=d367b0fd99" target="_blank"><span style='color:#084C9E;text-decoration:none'><img border=0 width=55 height=20 id="_x0000_i1043" src="http://cdn-images.mailchimp.com/social_connect_tweet.png" alt="share on Twitter"></span></a><o:p></o:p></span></p></td><td width=60 style='width:45.0pt;border:none;padding:0cm 0cm 15.0pt 0cm'><p class=MsoNormal style='line-height:150%'><span style='font-size:10.0pt;line-height:150%;font-family:"Helvetica","sans-serif";color:#303030'><a href="http://prostatecancernewstoday.us5.list-manage.com/track/click?u=52c64784d386bd00ea57ee792&id=162a7eefe2&e=d367b0fd99" title="Like Metastatic Prostate Cancer Patients in UK Can Now Have Routine Radium-223 Therapy on Facebook" id=fblike-06404cec><span style='color:#084C9E;text-decoration:none'><img border=0 width=48 height=20 id="_x0000_i1044" src="http://cdn-images.mailchimp.com/fb/like.gif" alt="Like Metastatic Prostate Cancer Patients in UK Can Now Have Routine Radium-223 Therapy on Facebook"></span></a><o:p></o:p></span></p></td></tr></table></td></tr></table></td></tr><tr><td valign=top style='padding:15.0pt 0cm 15.0pt 0cm'><h4>Recent Posts<o:p></o:p></h4><p class=MsoNormal style='line-height:150%'><span style='font-size:10.0pt;line-height:150%;font-family:"Helvetica","sans-serif";color:#303030'><a href="http://prostatecancernewstoday.us5.list-manage2.com/track/click?u=52c64784d386bd00ea57ee792&id=31306ebb4e&e=d367b0fd99" target="_blank"><span style='color:#084C9E'>Radiotherapy Plus ADT Seen to Improve Survival in Advanced Prostate Cancers</span></a><br><a href="http://prostatecancernewstoday.us5.list-manage1.com/track/click?u=52c64784d386bd00ea57ee792&id=2897803939&e=d367b0fd99" target="_blank"><span style='color:#084C9E'>Rosetta Genomics’ FISH Testing Services to Be Used in Prostate Cancer Study</span></a><br><a href="http://prostatecancernewstoday.us5.list-manage1.com/track/click?u=52c64784d386bd00ea57ee792&id=d6bf91e610&e=d367b0fd99" target="_blank"><span style='color:#084C9E'>New MRI Technique Could Help Early Prostate Cancer Detection</span></a><br><a href="http://prostatecancernewstoday.us5.list-manage.com/track/click?u=52c64784d386bd00ea57ee792&id=02a6ba9ef5&e=d367b0fd99" target="_blank"><span style='color:#084C9E'>Early-stage Prostate Cancer Rates Continued to Decline After Task Force Recommendations</span></a> <o:p></o:p></span></p></td></tr><tr><td valign=top style='padding:15.0pt 0cm 0cm 0cm'><div align=center><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width=560 style='width:420.0pt'><tr><td valign=top style='padding:0cm 0cm 0cm 0cm'></td><td width=40 style='width:30.0pt;padding:0cm 0cm 0cm 0cm'></td><td width=260 valign=top style='width:195.0pt;padding:0cm 0cm 0cm 0cm'><p class=MsoNormal><img border=0 id="_x0000_i1045" src="http://gallery.mailchimp.com/653153ae841fd11de66ad181a/images/transparent.gif"><o:p></o:p></p></td></tr></table></div></td></tr></table></div></td></tr></table></div></td></tr></table></div></td></tr><tr><td valign=top style='padding:0cm 0cm 0cm 0cm'><div align=center><table class=MsoNormalTable border=1 cellspacing=0 cellpadding=0 width=600 style='width:450.0pt;border:none;border-top:solid white 1.0pt' id=templateFooter><tr><td valign=top style='border:none;padding:30.0pt 0cm 30.0pt 0cm'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%'><tr><td valign=top style='padding:0cm 15.0pt 0cm 0cm'><p class=MsoNormal><em>Copyright © 2016 BioNews Services, LLC, All rights reserved.</em> <br>You are receiving this email because you opted in at our website <a href="http://prostatecancernewstoday.com">http://prostatecancernewstoday.com</a>. <br><br><strong>Our mailing address is:</strong> <o:p></o:p></p><div><p class=MsoNormal><span class=org>BioNews Services, LLC</span><o:p></o:p></p><div><div><p class=MsoNormal>5307 E. Mockingbird Ln.<o:p></o:p></p></div><div><p class=MsoNormal>Fifth Floor<o:p></o:p></p></div><p class=MsoNormal><span class=locality>Dallas</span>, <span class=region>TX</span> <span class=postal-code>75206</span><o:p></o:p></p></div><p class=MsoNormal><br><a href="http://prostatecancernewstoday.us5.list-manage.com/vcard?u=52c64784d386bd00ea57ee792&id=a6d9c27ca8"><span style='color:#505050'>Add us to your address book</span></a><o:p></o:p></p></div></td><td width=200 valign=top style='width:150.0pt;padding:0cm 0cm 0cm 0cm' id=monkeyRewards><p class=MsoNormal><a href="http://www.mailchimp.com/monkey-rewards/?utm_source=freemium_newsletter&utm_medium=email&utm_campaign=monkey_rewards&aid=52c64784d386bd00ea57ee792&afl=1"><span style='color:#505050;text-decoration:none'><img border=0 width=139 height=54 id="_x0000_i1046" src="http://cdn-images.mailchimp.com/monkey_rewards/MC_MonkeyReward_15.png" alt="Email Marketing Powered by MailChimp"></span></a><o:p></o:p></p></td></tr><tr><td colspan=2 style='padding:15.0pt 0cm 0cm 0cm'><p class=MsoNormal><a href="http://prostatecancernewstoday.us5.list-manage1.com/unsubscribe?u=52c64784d386bd00ea57ee792&id=a6d9c27ca8&e=d367b0fd99&c=458aa9aafa"><span style='color:#505050'>unsubscribe from this list</span></a> | <a href="http://prostatecancernewstoday.us5.list-manage.com/profile?u=52c64784d386bd00ea57ee792&id=a6d9c27ca8&e=d367b0fd99"><span style='color:#505050'>update subscription preferences</span></a> <o:p></o:p></p></td></tr></table></td></tr></table></div></td></tr></table></div><p class=MsoNormal><img border=0 width=1 height=1 id="_x0000_i1047" src="http://prostatecancernewstoday.us5.list-manage.com/track/open.php?u=52c64784d386bd00ea57ee792&id=458aa9aafa&e=d367b0fd99"><o:p></o:p></p></div></body></html>